Status:
RECRUITING
6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair
Lead Sponsor:
Vita Green Pharmaceutical (H.K.) Ltd.
Conditions:
Alopecia
Canities
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This will be a 6-month randomized, double-blind, placebo-controlled trial. A total of 152 participants with hair loss, including some with gray hair, will be enrolled and randomly assigned to four gro...
Eligibility Criteria
Inclusion
- Participants must sign the informed consent form prior to enrollment and fully understand the study's purpose, procedures, and potential adverse events.
- Adults aged 18 to 60 years, both male and female; each group must include no less than 50% female participants.
- Hair length must be greater than 5 cm.
- Women must meet the Savin scale classification between grades 1-3 to II.
- Men must meet the Norwood-Hamilton classification between stages II and VI.
- At least 10 participants in each group must have gray hair, with a minimum of 5 gray hairs within a 1 cm × 4 cm area of the scalp.
- Participants must not have undergone any special hair treatments-such as dyeing, perming, or styling-within the past two months.
Exclusion
- Pregnant or breastfeeding women, or individuals planning to conceive in the near future.
- Individuals with medical conditions causing hair loss, such as refractory alopecia areata, inflammatory scarring alopecia, or psoriatic alopecia; or those diagnosed with other scalp or hair disorders.
- Individuals with diagnosed psychiatric or psychological disorders, or those with long-term sleep disturbances or emotional regulation issues.
- Use of anti-hair loss cosmetics or other hair growth-promoting products within the past 3 months.
- Use of any systemic or topical medications known to affect hair growth within the past 6 months.
- History of hair transplantation.
- Curly hair.
- Individuals with highly sensitive constitutions.
- Individuals diagnosed with severe anemia or abnormal liver/kidney function during physical examination.
- Participation in any other clinical trials involving the test area within the past 2 months.
- Any other conditions deemed unsuitable for participation by the clinical investigators.
Key Trial Info
Start Date :
July 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2026
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT06998680
Start Date
July 30 2025
End Date
October 30 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First People's Hospital of Xiangtan City
Xiangtan, Hunan, China, 411100